Drug Policy Archives - Page 2 of 56

Ibogaine and veterans’ mental health

Backgrounder by Aubri Strachan

Ibogaine offers breakthrough treatment for mental health, addiction, and TBIs

Backgrounder by Aubri Strachan

Best practices to prevent misuse of opioid settlement funds

Commentary by Layal Bou Harfouch and Mariana Trujillo

Psychedelics Policy Newsletter: DEA considers rescheduling psilocybin, FDA releases rejection decision, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — October 2025

Commentary by Gregory Ferenstein

Restricting mobile health vans in Philadelphia will lead to more overdose deaths

Commentary by Layal Bou Harfouch

Harm reduction: An evidence-based approach to the drug war

Policy Brief by Layal Bou Harfouch

An evolving legal landscape for marijuana and firearms

Commentary by Jacob James Rich

Why New Mexico’s newborn state custody directive is a harmful misstep

Commentary by Layal Bou Harfouch

More Drug Policy

Prev
1
2
3
4
5
6
7
...
56
Next